Literature DB >> 33847144

Diphenhydramine and levofloxacin combination therapy against antimicrobial resistance in respiratory tract infections.

Sadaf Areej1, Adeel Sattar1, Aqeel Javeed1, Sohail Raza2.   

Abstract

Background: Antibiotics are in use since decades to treat various infections caused by Gram-positive and Gram-negative bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. Diphenhydramine, an H1 receptor blocker possesses a weak antibiotic action but when combined with other antibiotics may potentiate their antibacterial activity. Materials & methods: This study investigated in vitro antibacterial activity of diphenhydramine when used alone and in combination with levofloxacin against methicillin-resistant S. aureus and P. aeruginosa.
Results: The combined antibacterial effect of the drugs against bacteria showed a fractional inhibitory concentration index of ≤0.5, in other words, synergism. No cytotoxicity was observed as percentage cell viability was >50%.
Conclusion: The combination of diphenhydramine and levofloxacin exerted antibacterial activity, and was not found to be cytotoxic when given in combination against P. aeruginosa and S. aureus.

Entities:  

Keywords:  Pseudomonas aeruginosa; Staphylococcus aureus; antibacterial effect; antimicrobial resistance; combination therapy; cytotoxic evaluation; diphenhydramine; levofloxacin; respiratory tract infections; synergism

Year:  2021        PMID: 33847144     DOI: 10.2217/fmb-2019-0346

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  2 in total

1.  Cilia Stimulatory and Antibacterial Activities of T2R Bitter Taste Receptor Agonist Diphenhydramine: Insights into Repurposing Bitter Drugs for Nasal Infections.

Authors:  Li Eon Kuek; Derek B McMahon; Ray Z Ma; Zoey A Miller; Jennifer F Jolivert; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-06

Review 2.  Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach.

Authors:  Alexia Barbarossa; Antonio Rosato; Filomena Corbo; Maria Lisa Clodoveo; Giuseppe Fracchiolla; Antonio Carrieri; Alessia Carocci
Journal:  Antibiotics (Basel)       Date:  2022-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.